Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Azithromycin vs Oral Doxycycline for MGD
NCT03162497Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2018
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in meibomian gland dysfunction (MGD), sponsored by Medical University of Vienna. Started Jan 2018; status: completed.
02
Drugs
azithromycin
03
Conditions
meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NCT03162497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03162497.